58 results
8-K
LQDA
Liquidia Corp
3 Jun 24
District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch
7:30am
Therapeutics”) filed a lawsuit against Liquidia Technologies, Inc., a Delaware corporation (“Liquidia Technologies”) and a wholly owned subsidiary
8-K
EX-99.1
LQDA
Liquidia Corp
3 Jun 24
District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch
7:30am
available to pulmonary arterial hypertension (PAH) and PH-ILD patients.”
The motion for preliminary injunction was filed in the lawsuit (Case No. 23-975 … the status quo in which there is no legal impediment to the FDA granting final approval to YUTREPIA, this lawsuit will continue forward to trial
8-K
EX-99.1
LQDA
Liquidia Corp
13 May 24
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
6:24pm
.
Awaiting ruling from District Court on preliminary injunction in new patent infringement lawsuit filed by United Therapeutics. United Therapeutics filed … a new patent infringement lawsuit against the company in Delaware District Court (Case No. 1:23-cv-00975-RGA) alleging that YUTREPIA infringes U.S
8-K
LQDA
Liquidia Corp
1 Apr 24
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
7:00am
”).
In the first action, United Therapeutics filed a lawsuit against the FDA in the U.S. District Court for the District of Columbia (the “D.C. District … Bates, who is presiding over this lawsuit in the D.C. District Court, denied United Therapeutics’ motion. The D.C. District Court has scheduled a status
8-K
EX-99.1
cs54hx6wz3uzpx
1 Apr 24
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
7:00am
8-K
w2d59
23 Jan 24
Other Events
7:30am
8-K
EX-99.2
xx359b
8 Jan 24
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
4:15pm
8-K
pah3o637
20 Dec 23
Other Events
5:16pm
8-K
EX-99.1
f6x7vxi9zz7pcomcdv
20 Dec 23
Other Events
5:16pm
424B2
yq8w0u1
12 Dec 23
Prospectus for primary offering
4:41pm
8-K
EX-99.1
i51p7hhc
7 Nov 23
Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:36am
8-K
EX-99.1
7bjk0bzu
6 Sep 23
United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
4:37pm